Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Bell

Showing results (101-110 of 102) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 102 results.
Neuro-Degenerative Diseases|September 7, 2006
Genetic variability in CHMP2B and frontotemporal dementiaParastoo Momeni, Ekaterina Rogaeva, Vivianna Van Deerlin, et al.
The Lancet. Oncology|May 2, 2025
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trialEmil Lou, Modassir S Choudhry, Timothy K Starr, et al.
Pageof 11

Showing results (101-110 of 102) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 102 results.
Neuro-Degenerative Diseases|September 7, 2006
Genetic variability in CHMP2B and frontotemporal dementiaParastoo Momeni, Ekaterina Rogaeva, Vivianna Van Deerlin, et al.
The Lancet. Oncology|May 2, 2025
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trialEmil Lou, Modassir S Choudhry, Timothy K Starr, et al.
Pageof 11